Regal Assets Analytics

Gritstone, BioXcel Expect to Report Catalysts in July 2020; 2Q SanaCurrents Update

By |2020-10-20T14:21:50-04:00July 6th, 2020|Tags: , , , , , , , , , , , , , , , , |

Gritstone Oncology (NASDAQ:GRTS) plans to hold a conference call and webcast at 8 am Eastern on July 13, 2020, to [...]

Acceleron Hits Second Catalyst; Eight More SanaCurrents Catalysts Expected For 2Q 2020

By |2020-04-15T11:07:58-04:00April 15th, 2020|Tags: , , , , , , , , , |

Onconova Coverage suspended, Oragenics falls short in Phase II trial.   The FDA last week approved Acceleron Pharma Inc. (NASDAQ:XLRN) luspatercept [...]

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) – 3Q 2019 catalyst, CBD treatment for Fragile X

By |2020-10-20T14:54:38-04:00November 21st, 2018|Tags: |

3Q ‘19 catalyst, CBD treatment for Fragile X SanaCurrents is providing a pivotal sentiment rating to the results of a [...]

Go to Top